Featured Research

from universities, journals, and other organizations

Radioactive antibody fragment may help scientists identify artery deposits

Date:
March 29, 2012
Source:
American Heart Association
Summary:
Creating a tiny, radioactive antibody fragment may help scientists identify artery deposits most likely to burst and cause a heart attack. A non-invasive system uses miniature antibodies to detect a molecule that identifies the vulnerable deposits. Researchers plan clinical trials to determine the safety and efficacy of the new imaging technique.

Creating a radioactive antibody fragment may allow scientists to identify fat and debris deposits in artery walls that are most likely to rupture and cause heart attacks , according to a new study in Circulation: Research, an American Heart Association journal.

Related Articles


Of the more than 17 million annual cardiovascular deaths worldwide, most result from ruptured plaque .

"The detection of vulnerable coronary plaques is a major clinical challenge because it would allow preventive patient management prior to a heart attack," said Alexis Broisat, Ph.D., the study's lead author and a post-doctoral fellow at the University of Grenoble in France. "In clinical practice, there is currently no early, reliable and noninvasive tool allowing such detection."

The researchers created radioactive antibody fragments called nanobodies that attached to particles in artery plaque called vascular cell adhesion molecule-1 (VCAM1).

"Nanobodies constitute a promising new class of radiotracers for cardiovascular imaging," Broisat said.

Ongoing inflammation in a plaque deposit is a crucial sign that the plaque may rupture, and VCAM1 plays a major role in the inflammation process.

In laboratory tests, the radioactive nanobodies were attracted to VCAM-1.

In animal tests, researchers injected a solution containing the radioactive particles into the blood stream of mice with artery plaques. They then used a single-proton emission computed tomography (SPECT/CT) imaging scan to detect the radioactive particles.

The nanobodies attached to VCAM-1 expressing tissues. Following radiolabeling, some of the nanobodies remained stable in the laboratory and in mouse blood for six hours. This allowed imaging of the mice up to three hours after nanobody injection. These scans revealed plaques in the animals' aortic arches.

If approved for human use, physicians can inject nanobodies into patients to determine if they are at risk of plaque rupture.

"The early detection of trouble looming ahead could trigger steps for intervention, possibly involving the aggressive modulation of risk factors," according to an editorial accompanying the report by Matthias Nahrendorf, M.D., Ph.D., Jason R. McCarthy, Ph.D., and Peter Libby, M.D., of Harvard Medical School in Boston, Mass.

Before the imaging concept can be used regularly, researchers must conduct toxicology studies, produce clinical-quality material and determine whether the radiotracer technique is safe, beneficial and cost effective.

Broisat and his colleagues are planning clinical studies of the radiotracer technique to address these issues, including whether the anti-VCAM1 nanobodies can trigger adverse immune system reactions in people.

Broisat's co-authors are: Sophie Hernot, Ph.D.; Jakub Toczek, M.Sc.; Jens De Vos, M.Sc.; Laurent M. Riou, Ph.D.; Sandrine Martin, Ph.D.; Mitra Ahmadi, Ph.D.; Nicole Thielens, Ph.D.; Ulrich Wernery, Ph.D.; Vicky Caveliers, Ph.D.; Serge Muyldermans, Ph.D.; Tony Lahoutte, M.D., Ph.D.; Daniel Fagret, M.D., Ph.D.; Catherine Ghezzi, Ph.D.; and Nick Devoogdt, Ph.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. Broisat, S. Hernot, J. Toczek, J. De Vos, L. M. Riou, S. Martin, M. Ahmadi, N. Thielens, U. Wernery, V. Caveliers, S. Muyldermans, T. Lahoutte, D. Fagret, C. Ghezzi, N. Devoogdt. Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions. Circulation Research, 2012; 110 (7): 927 DOI: 10.1161/CIRCRESAHA.112.265140

Cite This Page:

American Heart Association. "Radioactive antibody fragment may help scientists identify artery deposits." ScienceDaily. ScienceDaily, 29 March 2012. <www.sciencedaily.com/releases/2012/03/120329170429.htm>.
American Heart Association. (2012, March 29). Radioactive antibody fragment may help scientists identify artery deposits. ScienceDaily. Retrieved March 2, 2015 from www.sciencedaily.com/releases/2012/03/120329170429.htm
American Heart Association. "Radioactive antibody fragment may help scientists identify artery deposits." ScienceDaily. www.sciencedaily.com/releases/2012/03/120329170429.htm (accessed March 2, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 2, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Treadmill Test Can Predict Chance Of Death Within A Decade

Treadmill Test Can Predict Chance Of Death Within A Decade

Newsy (Mar. 2, 2015) Johns Hopkins researchers analyzed 58,000 heart stress tests to come up with a formula that predicts a person&apos;s chances of dying in the next decade. Video provided by Newsy
Powered by NewsLook.com
Going Gluten-Free Could Get You A Tax Break

Going Gluten-Free Could Get You A Tax Break

Newsy (Mar. 2, 2015) If a doctor advises you to remove gluten from your diet, you could get a tax deduction on the amount you spend on gluten-free foods. Video provided by Newsy
Powered by NewsLook.com
GlaxoSmithKline and Novartis Try Swapping Success

GlaxoSmithKline and Novartis Try Swapping Success

Reuters - Business Video Online (Mar. 2, 2015) GlaxoSmithKline and Novartis have completed a series of asset swaps worth more than $20 billion. As Grace Pascoe reports they say the deal will reshape both drugmakers. Video provided by Reuters
Powered by NewsLook.com
How Can West Africa Rebuild After Ebola?

How Can West Africa Rebuild After Ebola?

Reuters - Business Video Online (Mar. 2, 2015) How best to rebuild the three West African countries struggling with Ebola will be discussed in Brussels this week. As Hayley Platt reports Sierra Leone has the toughest job ahead - its once thriving economy has been ravaged by the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins